![DTB Podcast artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts123/v4/b7/ff/e6/b7ffe69d-a833-7d17-5986-c91912b9c87a/mza_4739691453721470086.png/100x100bb.jpg)
Penicillin allergy, lecanemab and Alzeimer's disease, a new oral contraceptive and statins for all
DTB Podcast
English - February 20, 2023 07:33 - 30 minutes - ★★★★★ - 4 ratingsScience Health & Fitness Medicine dtb drug and therapeutics bulletin therapy medical evidence Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the March 2023 issue of DTB. They discuss incorrect penicillin allergy labels and ways that these can be corrected (https://dtb.bmj.com/content/61/3/34). They review clinical trial results for lecanameb in early Alzheimer's disease (https://dtb.bmj.com/content/61/3/37) and also talk about a new combined oral contraceptive that contains estetrol and drospirenone (https://dtb.bmj.com/content/61/3/39). They begin by discussing a proposal from the National Institute for Health and Care Excellence to lower the threshold for offering statins for primary prevention.
The contact address for the DTB team is [email protected].
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.